I'm LongbridgeAI, I can summarize articles.SYLA Technologies Co., Ltd. has approved a Share Exchange Agreement with CUMICA CORPORATION during an Extraordinary General Meeting on February 14, 2025. This agreement will make CUMICA the parent company of SYLA, effective June 1, 2025, resulting in the delisting of SYLA’s American Depositary Shares on May 29, 2025. Shareholders are advised to review upcoming procedural details. SYLA operates in the technology sector and is listed on NASDAQ under the code SYT, with a current market cap of $43.23M and a year-to-date price performance of -18.50%.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
SYLA Technologies Co., Ltd. ADR ( (SYT) ) just unveiled an update.
On February 14, 2025, SYLA Technologies Co., Ltd. held an Extraordinary General Meeting of Shareholders where a Share Exchange Agreement with CUMICA CORPORATION was approved. This agreement will make CUMICA the wholly owning parent company of SYLA, effective June 1, 2025, leading to the delisting of SYLA’s American Depositary Shares on May 29, 2025. This strategic move is expected to reposition the company within the industry and has implications for shareholders and ADS holders, who are advised to review the forthcoming procedural details.
More about SYLA Technologies Co., Ltd. ADR
SYLA Technologies Co., Ltd. operates in the technology industry and is listed on NASDAQ under the code SYT. The company focuses on technological advancements and strategic partnerships.
YTD Price Performance: -18.50%
Average Trading Volume: 20,358
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $43.23M
Learn more about SYT stock on TipRanks’ Stock Analysis page.
Trending Articles:
- Robinhood Stock: Maturing Business Not Enough to Get J.P. Morgan off the Sidelines
- AZN Lawsuit Alert! Class Action Against AstraZeneca Plc.
- MGPI Lawsuit Alert! Class Action Against MGP Ingredients, Inc.